NewcelX NCEL
NASDAQ NCEL
$2.79 +0.03 (+1.05%)
As of: Oct 21, 2026 · 3:59 PM EDT

NewcelX (NCEL) Operating Leases (2022 - 2023)

Updated

NewcelX's Operating Leases came in at $164,000 for Q2 2023.

Analysis

NewcelX (NCEL) Operating Leases (2022 - 2023) Analysis & Trends

At the end of FY2022, NewcelX's Operating Leases was $444,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 NewcelX 11.34 Mn 4.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 164,000.00
Dec 31, 2022 444,000.00
API Access

NewcelX Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=NCEL&period=max&api_key=YOUR_API_KEY